American Cyanamid
American manufacturing conglomerate that expanded from fertilizer and industrial chemicals into pharmaceuticals, agricultural chemicals, consumer products, and medical products before being acquired by American Home Products in 1994.
Last updated August 24, 2026
Overview
American Cyanamid was a major American manufacturing conglomerate founded in 1907 by engineers Frank S. Washburn and Charles H. Baker. It began by commercializing calcium cyanamide, a nitrogen compound used as fertilizer, under technology licensed from Germany. The company’s early plans involved integrated chemical manufacturing and hydroelectric power facilities in the United States and Canada. Although its intended Alabama operation at Muscle Shoals was delayed by disputes over dam construction and federal control of the site, the company established an operating Canadian plant in 1910 and later acquired fertilizer assets in New Jersey. World War I redirected part of American Cyanamid’s nitrogen capacity toward explosives and military materials. Through the Air Nitrates Corporation, it participated in the federally supported development of the Muscle Shoals facility. The arrangement attracted allegations of political favoritism and was later examined by the Department of Justice, although the federal case did not proceed for lack of sufficient evidence. After the war, the company continued building its fertilizer and chemical businesses, including through the 1917 acquisition of Ammo-Phosphate Corporation. The company’s most important strategic shift came in 1930, when it acquired Lederle Laboratories. This move established pharmaceuticals as a central business alongside chemicals and agriculture. Lederle developed or marketed products including chlortetracycline, methotrexate, piperacillin, vaccines, and nutritional supplements. During the 1930s and World War II, American Cyanamid supplied typhus vaccine and anti-gangrene products. It also expanded into surgical products and medical devices through Davis & Geck. After World War II, American Cyanamid became increasingly diversified. Its portfolio included synthetic fibers, plastics, inorganic pigments, specialty chemicals, agricultural products, pharmaceuticals, cosmetics, toiletries, fragrances, building materials, and household products. Consumer brands associated with the company included Old Spice, Breck shampoo, Pine-Sol, Centrum, and Stresstabs. The company also owned or licensed brands such as Melmac plastic kitchenware and fragrance labels including Nina Ricci, Pierre Cardin, and Tabac. Its chemical operations included large facilities such as the Fortier plant in Waggaman, Louisiana. By the 1970s, American Cyanamid had become a large international employer and a New York Stock Exchange-listed company trading under the symbol ACY. Growth was accompanied by labor disputes, environmental controversies, industrial accidents, and regulatory scrutiny. Pollution associated with chemical sites in New Jersey and elsewhere later resulted in major remediation obligations. The company also faced litigation concerning pharmaceuticals, industrial safety, labor practices, antitrust matters, and alleged discriminatory employment policies. Financial and organizational pressures increased in the early 1990s. In 1994, American Cyanamid was acquired by American Home Products in a transaction valued at approximately $9.5 billion. The combined company subsequently dismantled much of Cyanamid’s former conglomerate structure. Its agricultural business was sold to BASF in 2000, chemical operations were largely separated into Cytec, and consumer brands and other divisions were sold to different owners. American Home Products eventually adopted the Wyeth name, and Wyeth was acquired by Pfizer in 2009. American Cyanamid therefore ceased to exist as an independent company, while parts of its former business continued under Pfizer, BASF, Cytec and other successor owners.
History
American Cyanamid was created in New York City in 1907 by Frank S. Washburn and Charles H. Baker. Its original business was based on calcium cyanamide, a nitrogen compound used in fertilizer production. The founders licensed German technology and envisioned an integrated manufacturing system supported by electric generation and utility infrastructure. They planned facilities in Alabama, Canada, Georgia, and at Niagara Falls. The Canadian plant began operating in 1910, while the proposed Alabama project was delayed after the company was denied permission to build the hydroelectric dam needed to power it. The company initially imported Canadian product into the United States while pursuing political and local support for the Alabama project. During World War I, nitrogen production became strategically important for explosives as well as fertilizer. American Cyanamid offered patents, processes, equipment, and personnel to the federal government, and the Air Nitrates Corporation was established to build and operate the Muscle Shoals facility. The arrangement generated criticism about preferential treatment, but the federal case concerning possible graft was eventually abandoned for insufficient evidence. In 1917, American Cyanamid acquired Ammo-Phosphate Corporation and gained a fertilizer plant at Linden, New Jersey. After Washburn’s death in 1922, the future of Muscle Shoals remained subject to political debate. Competing proposals involving American Cyanamid, General Electric, Henry Ford, Union Carbide, local utilities, and financial groups were considered during the 1920s. None was accepted, and the federal government ultimately retained control of the plants. American Cyanamid instead expanded through other assets and technologies. The 1930 purchase of Lederle Laboratories transformed the company. Lederle brought pharmaceuticals, vaccines, and biological research into the group and later became associated with products such as chlortetracycline, methotrexate, piperacillin, oral polio vaccine, and nutritional supplements. American Cyanamid supplied typhus vaccine and anti-gangrene products during the 1930s and World War II. Its medical products business also included Davis & Geck, which operated under the Lederle organization. The postwar company became a broad conglomerate. It developed or acquired businesses in synthetic fibers, plastics, pigments, industrial chemicals, agricultural chemicals, pharmaceuticals, surgical products, toiletries, cosmetics, fragrances, household cleaners, and building materials. Its consumer portfolio included Old Spice, Breck, and Pine-Sol, while Centrum and Stresstabs became notable health-product brands. Its chemical operations included the Fortier plant in Waggaman, Louisiana, which manufactured products including acrylonitrile, hydrogen cyanide, melamine, oleum, and sulfuric acid. By the 1970s, the company had more than 100,000 employees worldwide, more than 200,000 shareholders, and a New York Stock Exchange listing under ACY. Expansion brought significant liabilities. American Cyanamid faced antitrust enforcement, union conflicts, allegations involving workplace health and safety, product-related litigation, industrial accidents, and extensive environmental pollution. In New Jersey, the Bound Brook–Bridgewater site became an EPA Superfund location because of decades of chemical contamination. Other incidents included sulfuric-acid discharges affecting Georgia waterways, a major toxic-fume release from the Linden insecticide facility in 1984, and a controversial policy at the Willow Island plant concerning women of child-bearing age and alleged lead exposure. The conglomerate weakened in the early 1990s, including a substantial decline in reported net earnings in 1991. American Cyanamid was acquired by American Home Products in 1994 for approximately $9.5 billion. The buyer subsequently sold or separated most Cyanamid businesses. The agricultural division went to BASF in 2000; chemical activities were largely placed in Cytec; consumer products such as Old Spice were sold to Procter & Gamble; and Formica was taken private through a management buyout. American Home Products later became Wyeth, which Pfizer acquired in 2009. Cytec was acquired by Solvay in 2015. The American Cyanamid name thus survives mainly through historical records, successor businesses, brands, and environmental sites rather than as an independent operating company.
- 2009Wyeth acquired by Pfizer
The former American Cyanamid pharmaceutical business, operating through Wyeth, became part of Pfizer.
- 2000Agricultural business sold to BASF
American Home Products sold the former Cyanamid agricultural business to BASF.
- 1994Acquired by American Home Products
The approximately $9.5 billion acquisition ended American Cyanamid as an independent company.
- 1983Bound Brook site designated for Superfund cleanup
The former New Jersey chemical compound was designated an EPA Superfund site because of extensive contamination.
- 1970Large international conglomerate
By the 1970s, American Cyanamid had become a globally operating company with more than 100,000 employees and a New York Stock Exchange listing.
- 1930Lederle Laboratories acquired
The acquisition established pharmaceuticals and biological products as a major part of the company.
- 1917Ammo-Phosphate acquisition
American Cyanamid acquired Ammo-Phosphate Corporation and its fertilizer plant in Linden, New Jersey.
- 1910Canadian manufacturing begins
The company’s Canadian plant became its first operating manufacturing facility.
- 1907Company founded
Frank S. Washburn and Charles H. Baker founded American Cyanamid to manufacture nitrogen fertilizer based on calcium cyanamide.
Products and positioning
A diversified industrial and life-sciences conglomerate whose identity evolved from fertilizer manufacturing into a broad portfolio spanning chemicals, pharmaceuticals, agriculture, consumer products, and medical technologies.
Lederle LaboratoriesPharmaceuticals and biological products1930
Acquired in 1930, Lederle became American Cyanamid’s principal pharmaceutical and biological-products division. Its activities included antibiotics, vaccines, chemotherapy, nutritional products, and related research. Products associated with the division included chlortetracycline, methotrexate, piperacillin, oral polio vaccine, and anti-infective products.
CentrumVitamins and supplements
Centrum was a major consumer health brand associated with American Cyanamid’s pharmaceutical and consumer-products operations. It positioned multivitamin supplementation as a mainstream health and nutrition product and later passed through successor ownership after the Cyanamid acquisition.
Old SpiceGrooming and fragrances
Old Spice was part of the Shulton consumer-products portfolio operated by American Cyanamid. The line centered on men’s fragrances, colognes, and after-shave products. It was later sold to Procter & Gamble during the breakup of the former conglomerate.
Agricultural chemicalsCrop protection and fertilizers1907
Agriculture remained connected to the company’s original fertilizer business and later included pesticides and other crop-protection products. The agricultural division was sold to BASF in 2000, substantially expanding BASF’s agricultural operations.
Industrial and specialty chemicalsIndustrial chemicals1907
American Cyanamid manufactured a wide range of industrial inputs, including nitrogen compounds, sulfuric acid, oleum, melamine, hydrogen cyanide, acrylonitrile, plastics, fibers, pigments, and specialty chemicals. Much of this activity was later separated into Cytec and subsequently transferred to other owners.
Davis & GeckMedical and surgical products
Davis & Geck operated as American Cyanamid’s medical-device and surgical-products business under the Lederle organization, extending the company’s healthcare portfolio beyond pharmaceuticals.
Shulton consumer productsConsumer products
The Shulton portfolio included Old Spice, Breck shampoo, Pine-Sol cleaner, and licensed fine-fragrance products associated with labels such as Nina Ricci, Pierre Cardin, and Tabac.
Flagship businesses
- Lederle Laboratories pharmaceuticals
- Centrum multivitamins
- Old Spice grooming products
- Pine-Sol cleaner
- Breck shampoo
- Agricultural chemicals
- Industrial chemicals produced at the Fortier and other manufacturing plants
Brand decisions
- 2009Wyeth acquired by PfizerM&A
The former pharmaceutical assets of American Cyanamid were operating within the Wyeth organization.
What changed. Pfizer acquired Wyeth.
Aftermath. A substantial portion of American Cyanamid’s former pharmaceutical business became part of Pfizer.
- 2000Sell agricultural business to BASFM&A
American Home Products continued restructuring and divesting the former Cyanamid conglomerate.
What changed. The agricultural business was sold to BASF.
Aftermath. The transaction strengthened BASF’s agricultural operations and removed another major Cyanamid business from the former corporate group.
- 1994Merge with American Home ProductsM&A
Declining earnings and the growing complexity of the conglomerate increased pressure for a major corporate transaction.
What changed. American Home Products acquired American Cyanamid in a transaction valued at approximately $9.5 billion.
Aftermath. American Cyanamid was dismantled over subsequent years, with businesses sold, spun off, or retained within the successor Wyeth organization.
Acquisition value. Approximately $9.5 billion (1994 acquisition)
- 1930Acquire Lederle LaboratoriesM&A
American Cyanamid sought to broaden its fertilizer and chemical base into pharmaceuticals and biological products.
What changed. The company acquired Lederle Laboratories and integrated it as a major pharmaceutical division.
Aftermath. Lederle became central to the company’s later healthcare portfolio and supplied medicines, vaccines, and nutritional products.
Leadership
| Name | Title | Tenure |
|---|---|---|
| Albert Costello | Chairman and Chief Executive Officerformer | 1993–1994 |
| Charles H. Baker | Co-founder and Vice Presidentformer | 1907– |
| Frank S. Washburn | Co-founder and Presidentformer | 1907–1922 |
Controversies
- 1985Second Linden insecticide leakControversy
Another leak at the Linden facility generated hundreds of complaints involving breathing difficulties and nausea in Brooklyn and Staten Island.
- 1984Linden toxic-fume releaseControversy
A toxic-fume cloud from the Linden insecticide plant affected a broad area of New Jersey and Staten Island. More than 160 people were hospitalized, nearby workers were evacuated, and residents received emergency instructions.
- 1983Bound Brook–Bridgewater contaminationControversy
The former 575-acre New Jersey chemical site was designated for Superfund cleanup because of long-term contamination involving industrial chemicals and polluted waste impoundments.
- 1978Linden labor and workplace-health strikeControversy
More than 1,300 workers at the Linden, New Jersey plant struck over management’s handling of alleged exposure to carcinogens, asbestos, and other workplace hazards.
- 1978Willow Island reproductive-risk employment policyControversy
At the Willow Island plant, women of child-bearing age were reportedly told to leave their jobs, accept demotion, or undergo sterilization after the company concluded that lead exposure might cause birth defects. The policy led to government action and civil-rights litigation.
- 1973Industrial discharge into Georgia waterwaysControversy
Georgia regulators ordered the company to stop discharging sulfuric acid into the Wilmington and Savannah Rivers after attributing fish kills to chemical pollution.
- 1964American Cyanamid explosionControversy
The company was associated with a serious industrial explosion in 1964, part of a broader history of safety incidents and regulatory scrutiny.
- 1942Antitrust violation fineControversy
American Cyanamid was fined for antitrust violations. The reported penalty was $453,461.
Recent events
- 2000BASF acquires American Cyanamid agricultural business
The former company’s agricultural operations were sold to BASF as American Home Products continued to break up the Cyanamid conglomerate.
M&A - 1994American Cyanamid merges with American Home Products
American Home Products acquired American Cyanamid in a transaction reported at approximately $9.5 billion, ending Cyanamid’s independent corporate existence.
M&A - 1930American Cyanamid acquires Lederle Laboratories
The acquisition gave American Cyanamid a substantial pharmaceutical platform and became a foundation for later expansion in medicines and biological products.
M&A - 1907American Cyanamid is founded to manufacture nitrogen fertilizer
Frank S. Washburn and Charles H. Baker established the company to exploit licensed technology for calcium cyanamide and related nitrogen products.
Other
Sources
Cite this profile: Cite the canonical profile. /brand-wiki/american-cyanamid · Editorial policy · How profiles are compiled